Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2517 (LINC02517) is a human gene producing a long non-coding RNA transcript (>200 nucleotides) that does not overlap protein-coding genes. LincRNAs are primarily nuclear molecules involved in regulating chromatin structure, transcription, and gene expression, often acting as fine-tuners of neighboring protein-coding genes or as enhancers. While many lincRNAs have functional roles in cell biology and disease (especially cancer), there is currently no published evidence of a disease-specific role, drug interaction, or clinical biomarker status for LINC02517 itself. The gene is cataloged in NCBI Gene (ID: 105374374) and Ensembl (ENSG00000249145). If you intend to use this for structured annotation or informatics, LINC02517 does not map to any canonical drug target class and should not be considered a receptor, enzyme, transporter, or similar unless further evidence emerges.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2517 (LINC02517).